BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9280887)

  • 1. [Cerebral positron emission tomographic study in systemic lupus erythematosus].
    Csépány T; Gulyás B; Trón L; Szakáll S; Kiss E; Kollár J; Sikula J; Szegedi G; Csiba L
    Orv Hetil; 1997 Aug; 138(31):1947-52. PubMed ID: 9280887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discrepancy between regional cerebral blood flow and glucose metabolism of the brain in systemic lupus erythematosus patients with normal brain magnetic resonance imaging findings.
    Kao CH; Ho YJ; Lan JL; Changlai SP; Liao KK; Chieng PU
    Arthritis Rheum; 1999 Jan; 42(1):61-8. PubMed ID: 9920015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations of cerebral glucose metabolism indicate progress to severe morphological brain lesions in neuropsychiatric systemic lupus erythematosus.
    Weiner SM; Otte A; Schumacher M; Brink I; Juengling FD; Sobanksi T; Nitzsche EU; Peter HH
    Lupus; 2000; 9(5):386-9. PubMed ID: 10878734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of FDG-PET, HMPAO-SPET and MRI in the detection of brain involvement in patients with systemic lupus erythematosus.
    Kao CH; Lan JL; ChangLai SP; Liao KK; Yen RF; Chieng PU
    Eur J Nucl Med; 1999 Feb; 26(2):129-34. PubMed ID: 9933346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positron emission tomography and magnetic resonance imaging for cerebral involvement in patients with systemic lupus erythematosus.
    Sailer M; Burchert W; Ehrenheim C; Smid HG; Haas J; Wildhagen K; Wurster U; Deicher H
    J Neurol; 1997 Mar; 244(3):186-93. PubMed ID: 9050960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and monitoring of central nervous system involvement in systemic lupus erythematosus: value of F-18 fluorodeoxyglucose PET.
    Weiner SM; Otte A; Schumacher M; Klein R; Gutfleisch J; Brink I; Otto P; Nitzsche EU; Moser E; Peter HH
    Ann Rheum Dis; 2000 May; 59(5):377-85. PubMed ID: 10784521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of fluorodeoxyglucose PET in the diagnosis of central nervous system lupus erythematosus and a comparison with CT and MRI].
    Stoppe G; Wildhagen K; Meyer GJ; Schober O
    Nuklearmedizin; 1989 Oct; 28(5):187-92. PubMed ID: 2813082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain glucose utilization in systemic lupus erythematosus with neuropsychiatric symptoms: a controlled positron emission tomography study.
    Otte A; Weiner SM; Peter HH; Mueller-Brand J; Goetze M; Moser E; Gutfleisch J; Hoegerle S; Juengling FD; Nitzsche EU
    Eur J Nucl Med; 1997 Jul; 24(7):787-91. PubMed ID: 9211766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropsychiatric systemic lupus erythematosus before and after immunosuppressive treatment: a FDG PET study.
    Otte A; Weiner SM; Hoegerle S; Wolf R; Juengling FD; Peter HH; Nitzsche EU
    Lupus; 1998; 7(1):57-9. PubMed ID: 9493152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebral involvement in systemic lupus erythematosus.
    Volkow ND; Warner N; McIntyre R; Valentine A; Kulkarni M; Mullani N; Gould L
    Am J Physiol Imaging; 1988; 3(2):91-8. PubMed ID: 3260788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positron emission tomography in neuropsychiatric lupus erythematosus.
    Stoppe G; Wildhagen K; Seidel JW; Meyer GJ; Schober O; Heintz P; Künkel H; Deicher H; Hundeshagen H
    Neurology; 1990 Feb; 40(2):304-8. PubMed ID: 2132733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropsychiatric systemic lupus erythematosus: correlation of brain MR imaging, CT, and SPECT.
    Abreu MR; Jakosky A; Folgerini M; Brenol JC; Xavier RM; Kapczinsky F
    Clin Imaging; 2005; 29(3):215-21. PubMed ID: 15855069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positron emission tomography with [(18)F]FDG in the diagnosis of Creutzfeldt-Jakob disease (CJD).
    Henkel K; Zerr I; Hertel A; Gratz KF; Schröter A; Tschampa HJ; Bihl H; Büll U; Grünwald F; Drzezga A; Spitz J; Poser S
    J Neurol; 2002 Jun; 249(6):699-705. PubMed ID: 12111302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pilot study of the use of 2-[18F]-fluoro-2-deoxy-D-glucose-positron emission tomography to assess the distribution of activated lymphocytes in patients with systemic lupus erythematosus.
    Nowak M; Carrasquillo JA; Yarboro CH; Bacharach SL; Whatley M; Valencia X; Takada K; Brust DG; Illei GG
    Arthritis Rheum; 2004 Apr; 50(4):1233-8. PubMed ID: 15077306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PET/CT imaging in systemic lupus erythematosus.
    Curiel R; Akin EA; Beaulieu G; DePalma L; Hashefi M
    Ann N Y Acad Sci; 2011 Jun; 1228():71-80. PubMed ID: 21718325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regional specific changes of cerebral metabolism in systemic lupus erythematosus identified by positron emission tomography.
    de Jong BM; Pruim J; Sinnige LG; Beintema KD; Spronk PE; Bootsma H; Kallenberg CG; van Zomeren AH; Haaxma-Reiche H
    Eur Neurol; 1999; 41(4):187-93. PubMed ID: 10343148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic lupus erythematosus presenting with diffuse low density lesions in the cerebral white matter on computed axial tomography scans: its implication in the pathogenesis of diffuse central nervous system lupus.
    Isshi K; Hirohata S; Hashimoto T; Miyashita H
    J Rheumatol; 1994 Sep; 21(9):1758-62. PubMed ID: 7799363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy of brain (18)F-fluorodeoxyglucose positron emission tomography in neuropsychiatric lupus patients with normal brain magnetic resonance imaging findings.
    Lee SW; Park MC; Lee SK; Park YB
    Lupus; 2012 Dec; 21(14):1531-7. PubMed ID: 22941565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional cerebral glucose metabolism in systemic lupus erythematosus patients with major depressive disorder.
    Saito T; Tamura M; Chiba Y; Katsuse O; Suda A; Kamada A; Ikura T; Abe K; Ogawa M; Minegishi K; Yoshimi R; Kirino Y; Ihata A; Hirayasu Y
    J Neurol Sci; 2017 Aug; 379():127-130. PubMed ID: 28716225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased regional cerebral metabolic rate for glucose in systemic lupus erythematosus patients with psychiatric symptoms.
    Komatsu N; Kodama K; Yamanouchi N; Okada S; Noda S; Nawata Y; Takabayashi K; Iwamoto I; Saito Y; Uchida Y; Ito H; Yoshikawa K; Sato T
    Eur Neurol; 1999 Jul; 42(1):41-8. PubMed ID: 10394047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.